Dr Rahil Barketali Roopani, MD | |
1800 116th Ave Ne Ste 102, Bellevue, WA 98004 | |
(425) 947-9485 | |
(425) 977-9034 |
Full Name | Dr Rahil Barketali Roopani |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Location | 1800 116th Ave Ne Ste 102, Bellevue, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013303734 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | MD61122148 (Washington) | Primary |
207R00000X | Internal Medicine | R4628 (Texas) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Dr Rahil Barketali Roopani, MD 455 Julie Rivers Dr, Sugar Land, TX 77478-3146 Ph: () - | Dr Rahil Barketali Roopani, MD 1800 116th Ave Ne Ste 102, Bellevue, WA 98004 Ph: (425) 947-9485 |
News Archive
An international study involving the Faculty of Medicine and Dentistry of the University of Valencia, recently published in 'The Lancet Psychiatry', highlights the importance of nutrition for maintaining mental health. Lecturer of Psychiatry Vicent Balanzá has participated in this study.
Writing in the Global Health Technologies Coalition's "Breakthroughs" blog, Eleonora Jimenez-Levi, a senior researcher at the Treatment Action Group (TAG), examines the 2012 Report on Tuberculosis Research Funding Trends: 2005–2011,"the latest report on the state of funding for tuberculosis (TB) research and product development."
Armaron Bio, a Melbourne-based drug development company focused on heart failure and other diseases, is pleased to announce that it has begun its Phase II clinical trial for NP202, its novel lead candidate drug for heart failure.
It seemed like a good idea at the time. But a health insurance tax credit for small businesses, part of President Barack Obama's health care law that gets strong support in public opinion polls, has turned out to be a disappointment. Time-consuming to apply for and lacking enough financial reward to make it attractive, the credit was claimed by only 170,300 businesses out of a pool of as many as 4 million potentially eligible companies in 2010.
OrthoAccel Technologies, Inc. announced this week that following a successful limited market release of AcceleDent last October it will be initiating a full-market release throughout the United Kingdom this coming September. Availability of AcceleDent, which is a regulated medical device and only available to dental professionals to prescribe to their patients, will be featured at the British Orthodontic Conference (BOC) next month in Brighton.
› Verified 2 days ago
Joseph W Doucette, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1135 116th Ave Ne, Suite 600, Bellevue, WA 98004 Phone: 425-454-2656 Fax: 425-990-5261 | |
Roanne R E Selinger, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1135 116th Ave Ne, #560, Bellevue, WA 98004 Phone: 425-454-4768 Fax: 425-462-8021 | |
Patsy C Lazarous, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 Fax: 844-620-1839 | |
Dr. Patricia Martin, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1407 116th Ave Ne, Suite 200, Bellevue, WA 98004 Phone: 425-454-5046 Fax: 425-990-5261 | |
David C Morton, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1135 116th Ave Ne, Suite 110a, Bellevue, WA 98004 Phone: 425-289-3100 Fax: 425-289-3103 | |
Shie-pon Tzung, MD PHD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1135 116th Ave Ne, #560, Bellevue, WA 98004 Phone: 425-454-4768 Fax: 425-462-8021 |